-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Initiates Coverage On Tyra Biosciences with Buy Rating, Announces Price Target of $54

Benzinga·04/15/2026 12:21:50
Listen to the news
Guggenheim analyst Brad Canino initiates coverage on Tyra Biosciences (NASDAQ:TYRA) with a Buy rating and announces Price Target of $54.